Literature DB >> 7601047

Endoscopic polypectomy and management of colorectal adenomas with invasive carcinoma.

A Hackelsberger1, P Frühmorgen, H Weiler, T Heller, H Seeliger, K Junghanns.   

Abstract

BACKGROUND AND STUDY AIMS: Invasive carcinoma is found at histology in 2-5% of colorectal polyps removed under flexible endoscopy. The aim of this study was to confirm that histologically complete endoscopic polypectomy under favorable low-risk conditions is sufficient therapy for pT1 carcinoma, while tumors at or close to the margin of the polypectomy, and histological high-risk criteria, require surgical resection with lymphadenectomy. PATIENTS AND METHODS: Eighty-six patients with 87 pT1 carcinomas underwent polypectomy within a twelve-and-a-half-year period. Further treatment prospectively followed the above guidelines. The follow-up was documented.
RESULTS: A local tumor residue was found in 5 of 34 patients who had undergone surgical resection for doubtful or incomplete polypectomy. Two patients were found to have nodal disease in the surgical specimen, only one of them harboring a high-risk carcinoma. Two further patients with high-risk carcinomas had tumor progression, despite postpolypectomy resections without local tumor residue or lymph-node infiltration, and died. One patient had a local tumor recurrence on follow-up endoscopy eight weeks after doubtfully complete polypectomy. He underwent resection, and had no further recurrence. No further manifestations of invasive carcinoma occurred after complete polypectomy of 42 patients with low-risk carcinomas.
CONCLUSIONS: This study supports the view that complete endoscopic polypectomy is an adequate therapy for low-risk carcinoma: A modification of the follow-up regimen, with less frequent endoscopic controls, is justified.

Entities:  

Mesh:

Year:  1995        PMID: 7601047     DOI: 10.1055/s-2007-1005654

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  12 in total

1.  Endoscopic submucosal dissection for colorectal tumors--1,000 colorectal ESD cases: one specialized institute's experiences.

Authors:  Eun-Jung Lee; Jae Bum Lee; Suk Hee Lee; Do Sun Kim; Doo Han Lee; Doo Seok Lee; Eui Gon Youk
Journal:  Surg Endosc       Date:  2012-06-23       Impact factor: 4.584

2.  Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.

Authors:  F Bianco; A Arezzo; F Agresta; C Coco; R Faletti; Z Krivocapic; G Rotondano; G A Santoro; N Vettoretto; S De Franciscis; A Belli; G M Romano
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

Review 3.  Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer.

Authors:  Hiroo Wada; Manabu Shiozawa; Kayoko Katayama; Naoyuki Okamoto; Yohei Miyagi; Yasushi Rino; Munetaka Masuda; Makoto Akaike
Journal:  J Gastroenterol       Date:  2015-03-01       Impact factor: 7.527

4.  Lymphatic invasion identified with D2-40 immunostaining as a risk factor of nodal metastasis in T1 colorectal cancer.

Authors:  Hiroo Wada; Manabu Shiozawa; Nobuhiro Sugano; Soichiro Morinaga; Yasushi Rino; Munetaka Masuda; Makoto Akaike; Yohei Miyagi
Journal:  Int J Clin Oncol       Date:  2012-11-01       Impact factor: 3.402

5.  Endoscopic submucosal dissection with a combination of small-caliber-tip transparent hood and flex knife for large superficial colorectal neoplasias including ileocecal lesions.

Authors:  Naoki Ishii; Toshiyuki Itoh; Noriyuki Horiki; Michitaka Matsuda; Takeshi Setoyama; Shoko Suzuki; Masayo Uemura; Yusuke Iizuka; Katsuyuki Fukuda; Koyu Suzuki; Yoshiyuki Fujita
Journal:  Surg Endosc       Date:  2010-01-29       Impact factor: 4.584

6.  Colon cancer screening update and management of the malignant polyp.

Authors:  James M Church
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  Histological factors contributing to a high risk of recurrence of submucosal invasive cancer (pT1) of the colon and rectum after endoscopic therapy.

Authors:  Ichiro Nakada; Takanobu Tabuchi; Takeshi Nakachi; Jiro Shimazaki; Satoru Konishi; Motonobu Katano; Hideyuki Ubukata; Yoshihisa Goto; Yoshinori Watanabe; Takafumi Tabuchi
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

8.  Risk factor assessment of endoscopically removed malignant colorectal polyps.

Authors:  P Netzer; C Forster; R Biral; C Ruchti; J Neuweiler; E Stauffer; R Schönegg; C Maurer; J Hüsler; F Halter; A Schmassmann
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 9.  [Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma].

Authors:  P Deinlein; U Reulbach; M Stolte; M Vieth
Journal:  Pathologe       Date:  2003-09       Impact factor: 1.011

Review 10.  The malignant adenoma: when to operate and when to watch.

Authors:  Peter J Mitchell; Najib Y Haboubi
Journal:  Surg Endosc       Date:  2008-03-25       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.